Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- BioSensics
- Study ID
- NCT07224386
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Myasthenia Gravis
- Myasthenia Gravis, Generalized
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Study Details
Evaluate the feasibility of using digital health technologies to monitor symptoms in myasthenia gravis (MG). Study subjects will be screened and enrolled at Massachusetts General Brigham Hospital to participate in this 12 month observational study. Study subjects will be asked to wear multiple wearable sensors to monitor their physical activity and PPG during daily activities. Participants will also complete speech, video, and ePRO and eCOA digital assessments at home and during study visits. The primary objective for this observational study is to measure the correlation of sensor-derived measures of physical activity to MG-specific ratings of MG-ADL, QMG, MGC, and Neuro-QoL Fatigue
Key Dates
- Start date
- Jan 1, 2026
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2027
- Completion
- Apr 30, 2028
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: Myasthenia GravisAll participants meeting the study inclusion criteria will be assigned to this group to complete the study activities
Primary Outcome Measure
Change in daily walking duration during activities of daily living from baseline to 12 months as measured by the PAMSys pendant [ Time Frame: From baseline 12 months. ]
Central Contacts
- Ashkan Vaziri, PhD8885896213
- Ana Enriquez88858962113
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital, Neuromuscular Diagnostic Center | Boston | Massachusetts | 02114 | Amanda Guidon, MD MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- A Study of Nipocalimab Administered to Adults With Generalized Myasthenia GravisPHASE3 · Recruiting · Janssen Research & Development, LLC · Paradise Valley, Arizona
- A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)PHASE1 · Recruiting · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Birmingham, Alabama
- A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod AlfaRecruiting · argenx · San Francisco, California
- Myasthenia Gravis Foundation of America Global MG Patient RegistryRecruiting · Myasthenia Gravis Foundation of America · Westborough, Massachusetts